CSL - Interest Expense On Debt

Stock Price
140.66
Daily Change
-0.37 -0.26%
Monthly
-7.19%
Yearly
-43.25%
Q1 Forecast
138.07

CSL reported $215M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Cara Therapeutics 43.75M 4.8M Jun/2025
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Esperion Therapeutics USD 22.64M 585K Dec/2025
Immunic 400K 400K Dec/2024
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
Sangamo BioSciences 97.56M 11.39M Jun/2025
TherapeuticsMD USD 20K 25K Sep/2023